The cytokine IL‐1β transiently enhances P2X7 receptor expression and function in human astrocytes
Top Cited Papers
- 7 October 2004
- Vol. 49 (2) , 245-258
- https://doi.org/10.1002/glia.20110
Abstract
Extracellular nucleotide di‐ and triphosphates such as ATP and ADP mediate their effects through purinergic P2 receptors belonging to either the metabotropic P2Y or the ionotropic P2X receptor family. The P2X7R is a unique member of the P2X family, which forms a pore in response to ligand stimulation, regulating cell permeability, cytokine release, and/or apoptosis. This receptor is also unique in that its affinity for the ligand benzoyl‐benzoyl ATP (BzATP) is at least 10‐fold greater than that of ATP. Primary human fetal astrocytes in culture express low‐levels of P2X7R mRNA and protein, and BzATP induces only a slight influx in intracellular calcium [Ca2+]i, with little demonstrable effect on gene expression or pore formation in these cells. We now show that, following treatment with the proinflammatory cytokine IL‐1β, BzATP induces a robust rise in [Ca2+]i with agonist and antagonist profiles indicative of the P2X7R. IL‐1β also induced the formation of membrane pores as evidenced by the uptake of YO‐PRO‐1 (375 Da). Quantitative real‐time PCR demonstrated transient upregulation of P2X7R mRNA in IL‐1β‐treated cells, while FACS analysis indicated a similar upregulation of P2X7R protein at the cell membrane. In multiple sclerosis lesions, immunoreactivity for the P2X7R was demonstrated on reactive astrocytes in autopsy brain tissues. In turn, P2X7R stimulation increased the production of IL‐1‐induced nitric oxide synthase activity by astrocytes in culture. These studies suggest that signaling via the P2X7R may modulate the astrocytic response to inflammation in the human central nervous system.Keywords
This publication has 71 references indexed in Scilit:
- Pharmacological and Biophysical Properties of the Human P2X5 ReceptorMolecular Pharmacology, 2003
- P2X7 Receptor Cell Surface Expression and Cytolytic Pore Formation Are Regulated by a Distal C-terminal RegionJournal of Biological Chemistry, 2003
- A QUANTITATIVE ANALYSIS OF PURINOCEPTOR EXPRESSION IN HUMAN FETAL AND ADULT BLADDERSJournal of Urology, 2001
- A Glu-496 to Ala Polymorphism Leads to Loss of Function of the Human P2X7 ReceptorJournal of Biological Chemistry, 2001
- Human monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ecto‐nucleotidasesFEBS Letters, 1999
- Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real‐time quantitative RT‐PCRBritish Journal of Haematology, 1998
- Extracellular ATP Activates Transcription Factor NF-κB through the P2Z Purinoreceptor by Selectively Targeting NF-κB p65 (RelA)The Journal of cell biology, 1997
- The isoquinoline derivative KN‐62 a potent antagonist of the P2Z‐receptor of human lymphocytesBritish Journal of Pharmacology, 1997
- The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell deathImmunology Today, 1995
- The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role.Journal of Clinical Investigation, 1995